GlassScriptPhysician profile
Fredric Chussid
NPI 1336296094
$7,912.06
in general payments reported to CMS, 2019-2025
42 companies · $1,604 in 2025
The $1,604 reported for 2025 was more than what 79% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,627 · 2020: $651 · 2021: $974 · 2022: $685 · 2023: $1,050 · 2024: $1,321 · 2025: $1,604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,976.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,975.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $1,795.57 | 2019-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Integra Lifesciences Corporation | $838.40 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Biotissue Holdings INC. | $654.65 | 2019-2025 | |
| Smith+Nephew, INC. | $568.48 | 2020-2025 | Stravix Pl, Grafix Pl, Oasis |
| Amniox Medical, INC. | $395.66 | 2019 | |
| Stryker Corporation | $351.56 | 2019-2025 | Prostep Mica, Augment Injectable, Ortholoc 3di |
| Treace Medical Concepts, INC. | $321.69 | 2022-2025 | |
| Polynovo North America LLC | $306.35 | 2025 | Novosorb Btm |
| Paratek Pharmaceuticals, INC. | $268.30 | 2021-2023 | Nuzyra |
| Cook Medical LLC | $189.68 | 2019 | |
| Organogenesis INC. | $174.30 | 2019-2024 | |
| Flower Orthopedics Coporation | $158.67 | 2023 | |
| Zimmer Biomet Holdings, INC. | $157.96 | 2020-2024 | Avitus Bone Harvester |
| Ibsa Pharma INC. | $148.57 | 2023-2024 | Licart, Tirosint, Licart |
| Access Pro Medical, LLC | $143.77 | 2025 | Matriderm |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $128.79 | 2019-2024 | Silverback, Monkey Rings |
| Depuy Synthes Sales INC. | $124.92 | 2025 | Na |
| Wright Medical Technology, INC. | $121.52 | 2019 | |
| Acell, INC. | $113.86 | 2019 | |
| Ethicon US, LLC | $100.12 | 2022 | |
| Saluda Medical Americas, INC. | $85.96 | 2024 | Evoke |
| Orthofix Medical, INC. | $83.42 | 2024 | Physio-Stim |
| Sebela Pharmaceuticals INC. | $80.37 | 2019 | |
| Misonix INC | $74.69 | 2020 | |
| Cardiovascular Systems INC. | $58.21 | 2021 | |
| Aroa Biosurgery Incorporated | $56.70 | 2024 | |
| Solventum Corporation | $50.04 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice, V.A.C.Ulta |
| Zyla Life Sciences, INC. | $41.04 | 2019 | |
| Bioventus LLC | $35.23 | 2019-2022 | |
| Horizon Therapeutics Plc | $28.00 | 2020-2021 | |
| International Life Sciences | $27.86 | 2024 | Flexband |
| Djo, LLC | $26.06 | 2023 | Cmf |
| Nevro Corp. | $25.04 | 2022 | |
| Metric Medical Devices, INC. | $24.95 | 2023 | Super Scaffold, Super Staple |
| Philips North America LLC | $23.60 | 2021 | |
| Amgen INC. | $22.61 | 2025 | Krystexxa |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $22.27 | 2023 | Jublia, Arazlo |
| Bsn Medical INC | $19.58 | 2025 | |
| Acera Surgical, INC. | $17.44 | 2024 | Restrata Wound Matrix |
| Linvatec Corporation | $15.83 | 2019 | |
| Cashflow Solutions, LLC | $15.79 | 2025 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Merck Sharp & Dohme LLC | $14.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fredric Chussid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.